Intuitive Surgical price target raised to $550 from $420 at Leerink Leerink raised its price target for Intuitive Surgical shares to $550 citing positive feedback on the just-released Xi system. The firm, however, keeps a Market Perform rating on the stock citing the recent rally.
Intuitive Surgical initiated with an Overweight, $575 target at Barclays Barclays analyst Matthew Taylor started shares of Intuitive Surgical with an Overweight rating and $575 price target. Taylor thinks surgery share will continue to shift to robotic and believes demand for Intuitive's da Vinci among general surgeons is very high. The stock closed yesterday down $4.17 to $492.45.